PALTech

🗓 Founded 2020👥 5 employees💰 Last funded Apr 2023
PALTech is a MedTech project aiming at treating Type 2 diabetes. The project is led by 2 scientists: - Dr. Reginald Allouche: a renowned diabetologist who has been working on this disease for many years - Pr. Charles-Henri Malbert: MD and DMV, pHD, Senior Research Director, head of Aniscan research Unit (Rennes, France), Adjunct Professor of Medicine University of Adelaide, Full Member of National Medicine Academy
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2020
Founded
Investor geography1 country
France
2
Frequently asked questions
Who invested in PALTech?
PALTech has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did PALTech last raise funding?
The most recent investment in PALTech recorded on gritt.io was in April 2023.
When was PALTech founded?
PALTech was founded in 2020.
What industry is PALTech in?
PALTech operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.